liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Ongoing Pharmacological Management of Chronic Pain in Pregnancy
Lund University, Sweden.
Linköping University, Department of Medical and Health Sciences, Division of Drug Research. Linköping University, Faculty of Medicine and Health Sciences. Skåne University Hospital, Sweden.ORCID iD: 0000-0002-6041-0744
2016 (English)In: Drugs, ISSN 0012-6667, E-ISSN 1179-1950, Vol. 76, no 9, 915-924 p.Article, review/survey (Refereed) PublishedText
Abstract [en]

The article discusses possible effects of the use of analgesics during pregnancy. It summarizes the pertinent literature and reports some previously unpublished data from the Swedish Medical Birth Register. Most likely the use of analgesics does not cause spontaneous abortion. Only small malformation risk increases are seen after the use of opioids and perhaps non-steroid anti-inflammatory drug (NSAID) use. If possible, the latter should be avoided during the first trimester. If exposure has occurred there is no reason to consider an interruption of the pregnancy. Continued use of analgesics may increase the risk of preeclampsia and of preterm birth, especially valid for opioids. Use of acetylsalicylic acid (ASA) in late pregnancy should be avoided because of the risk of bleeding and (valid also for NSAIDs) premature closure of the ductus arteriosus. A small risk for neonatal abstinence syndrome may exist after the use of opioids for chronic pain, notably during the third trimester and long-lasting effects on child development can possibly occur. For a woman with chronic pain, adequate use of pain killers during pregnancy is needed. It is prudent to avoid ASA and NSAIDs towards the end of the pregnancy, while acetaminophen is an acceptable option all through pregnancy. If continued use of opioids is necessary, the associated risks are low. Triptans can be used for migraine during pregnancy. If possible sumatriptan is preferable to other triptans as data for the latter are largely lacking. Ergots are preferably avoided as not enough data are available.

Place, publisher, year, edition, pages
ADIS INT LTD , 2016. Vol. 76, no 9, 915-924 p.
National Category
Pharmaceutical Sciences
Identifiers
URN: urn:nbn:se:liu:diva-130136DOI: 10.1007/s40265-016-0582-3ISI: 000377933100001PubMedID: 27154242OAI: oai:DiVA.org:liu-130136DiVA: diva2:948562
Available from: 2016-07-12 Created: 2016-07-11 Last updated: 2016-07-12

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Reis, Margareta
By organisation
Division of Drug ResearchFaculty of Medicine and Health Sciences
In the same journal
Drugs
Pharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 9 hits
ReferencesLink to record
Permanent link

Direct link